Bioprinting bladder tissue
Certain conditions, including inflammation and cancer, require augmentation of the urinary bladder. However, the conventional approach of using bowel tissue suffers from risks and post-surgery complications. The EU-funded UroPrint project proposes to engineer bladder tissue for autologous transplantation using laser-induced forward transfer (LIFT) bioprinting technology. Using a prototype bioprinter, researchers will graft primary urothelial and smooth muscle cells onto a natural scaffold ensuring high cell viability and mimicking the function of the human bladder. UroPrint is expected to improve clinical outcomes and the quality of life of patients by reducing hospitalisation.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action
1081 HV Amsterdam